116 related articles for article (PubMed ID: 35016423)
1. Characteristics of spinal dissemination in adult low-grade glioma: a retrospective cohort study at a single institute.
Chen J; Shi Q; Li S; Zhao Y; Huang H
Ann Palliat Med; 2021 Dec; 10(12):12643-12649. PubMed ID: 35016423
[TBL] [Abstract][Full Text] [Related]
2. A Retrospective Study on Spinal Dissemination of Supratentorial Glioma.
Chen J; Yang F; Shi Q; Zhao Y; Huang H
Front Oncol; 2021; 11():765399. PubMed ID: 35004286
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of glioblastoma with metastatic spinal dissemination.
Chen J; Shi Q; Li S; Zhao Y; Huang H
Ann Palliat Med; 2022 Feb; 11(2):506-512. PubMed ID: 35249328
[TBL] [Abstract][Full Text] [Related]
4. Corpus callosum involvement and postoperative outcomes of patients with gliomas.
Chen KT; Wu TW; Chuang CC; Hsu YH; Hsu PW; Huang YC; Lin TK; Chang CN; Lee ST; Wu CT; Tseng CK; Wang CC; Pai PC; Wei KC; Chen PY
J Neurooncol; 2015 Sep; 124(2):207-14. PubMed ID: 26033546
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic significance of neoplastic central nervous system tumor classification for patients with low grade glioma].
Jiang HH; Li G; Wang JM; Li XL; Cui Y; Lin S
Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(5):332-335. PubMed ID: 29429241
[No Abstract] [Full Text] [Related]
6. Progressive Low-Grade Glioma: Assessment of Prognostic Importance of Histologic Reassessment and MRI Findings.
Narang AK; Chaichana KL; Weingart JD; Redmond KJ; Lim M; Olivi A; Quinones-Hinojosa A; Kleinberg LR
World Neurosurg; 2017 Mar; 99():751-757. PubMed ID: 27108796
[TBL] [Abstract][Full Text] [Related]
7. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
[TBL] [Abstract][Full Text] [Related]
8. Surgical management of incidentally discovered diffusely infiltrating low-grade glioma.
Opoku-Darko M; Lang ST; Artindale J; Cairncross JG; Sevick RJ; Kelly JJP
J Neurosurg; 2018 Jul; 129(1):19-26. PubMed ID: 28984519
[TBL] [Abstract][Full Text] [Related]
9. Surgery for Diffuse WHO Grade II Gliomas: Volumetric Analysis of a Multicenter Retrospective Cohort From the German Study Group for Intraoperative Magnetic Resonance Imaging.
Scherer M; Ahmeti H; Roder C; Gessler F; Jungk C; Pala A; Mayer B; Senft C; Tatagiba M; Synowitz M; Wirtz CR; Unterberg AW; Coburger J
Neurosurgery; 2020 Jan; 86(1):E64-E74. PubMed ID: 31574147
[TBL] [Abstract][Full Text] [Related]
10. 3D-ASL perfusion correlates with VEGF expression and overall survival in glioma patients: Comparison of quantitative perfusion and pathology on accurate spatial location-matched basis.
Pang H; Dang X; Ren Y; Zhuang D; Qiu T; Chen H; Zhang J; Ma N; Li G; Zhang J; Wu J; Feng X
J Magn Reson Imaging; 2019 Jul; 50(1):209-220. PubMed ID: 30652410
[TBL] [Abstract][Full Text] [Related]
11. Metastatic Low-Grade Gliomas in Children: 20 Years' Experience at St. Jude Children's Research Hospital.
Chamdine O; Broniscer A; Wu S; Gajjar A; Qaddoumi I
Pediatr Blood Cancer; 2016 Jan; 63(1):62-70. PubMed ID: 26312767
[TBL] [Abstract][Full Text] [Related]
12. Management of pediatric intracranial low-grade gliomas: long-term follow-up after radiation therapy.
Huynh-Le MP; Walker AJ; Burger PC; Jallo GI; Cohen KJ; Wharam MD; Terezakis SA
Childs Nerv Syst; 2016 Aug; 32(8):1425-30. PubMed ID: 27179530
[TBL] [Abstract][Full Text] [Related]
13. Craniospinal irradiation for treatment of metastatic pediatric low-grade glioma.
Tsang DS; Murphy ES; Ezell SE; Lucas JT; Tinkle C; Merchant TE
J Neurooncol; 2017 Sep; 134(2):317-324. PubMed ID: 28623604
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy in adult low-grade glioma: nationwide trends in treatment and outcomes.
Nunna RS; Khalid S; Ryoo JS; Sethi A; Byrne RW; Mehta AI
Clin Transl Oncol; 2021 Mar; 23(3):628-637. PubMed ID: 32691365
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology.
Gnekow AK; Falkenstein F; von Hornstein S; Zwiener I; Berkefeld S; Bison B; Warmuth-Metz M; Driever PH; Soerensen N; Kortmann RD; Pietsch T; Faldum A
Neuro Oncol; 2012 Oct; 14(10):1265-84. PubMed ID: 22942186
[TBL] [Abstract][Full Text] [Related]
16. The impact of adjuvant therapy for patients with high-risk diffuse WHO grade II glioma.
Youland RS; Kreofsky CR; Schomas DA; Brown PD; Buckner JC; Laack NN
J Neurooncol; 2017 Dec; 135(3):535-543. PubMed ID: 28836106
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
[TBL] [Abstract][Full Text] [Related]
18. Patterns of care and outcomes of multi-agent versus single-agent chemotherapy as part of multimodal management of low grade glioma.
Haque W; Verma V; Butler EB; Teh BS
J Neurooncol; 2017 Jun; 133(2):369-375. PubMed ID: 28432588
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
[TBL] [Abstract][Full Text] [Related]
20. Combined carboplatin and etoposide chemotherapy for patients with recurrent glioma.
Chen J; Zhao Y; Hou X; Gao X; Shi Q; Li S; Huang H
Ann Palliat Med; 2021 Dec; 10(12):12650-12656. PubMed ID: 35016422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
